| Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments HYK Yip, A Papa Cells 10 (3), 659, 2021 | 171 | 2021 |
| Modulatory effects and action mechanisms of tryptanthrin on murine myeloid leukemia cells HL Chan, HY Yip, NK Mak, KN Leung Cellular & Molecular Immunology 6 (5), 335-342, 2009 | 72 | 2009 |
| Colonic myofibroblast cell line stimulates colonoid formation Y Hirokawa, KHY Yip, CW Tan, AW Burgess American Journal of Physiology-Gastrointestinal and Liver Physiology, 2014 | 37 | 2014 |
| Colon organoid formation and cryptogenesis are stimulated by growth factors secreted from myofibroblasts HYK Yip, CW Tan, Y Hirokawa, AW Burgess PloS one 13 (6), e0199412, 2018 | 34 | 2018 |
| Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor Suppression HYK Yip, A Chee, CS Ang, SY Shin, LM Ooms, Z Mohammadi, ... Molecular Cell 80 (2), 279-295. e8, 2020 | 21 | 2020 |
| PtdIns (3, 4, 5) P3-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis N Srijakotre, HJ Liu, M Nobis, J Man, HYK Yip, A Papa, HE Abud, ... Proceedings of the National Academy of Sciences 117 (45), 28056-28067, 2020 | 16 | 2020 |
| Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer PM Nguyen, LF Dagley, A Preaudet, N Lam, M Giam, KY Fung, K Aizel, ... Cell Death & Differentiation 27 (2), 742-757, 2020 | 13 | 2020 |
| Generation and functional characterization of murine mammary organoids HYK Yip, A Papa STAR protocols 2 (3), 100765, 2021 | 8 | 2021 |
| Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells 2021, 10, 659 HYK Yip, A Papa s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 2 | 2021 |
